M&A Deal Summary |
|
---|---|
Date | 2021-10-22 |
Target | Lemonaid Health |
Sector | Healthcare Services |
Buyer(s) | 23andMe |
Deal Type | Add-on Acquisition |
Deal Value | 400M USD |
Advisor(s) | Fenwick & West Nelson Hardiman (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2006 |
Sector | Life Science |
Employees | 560 |
Revenue | 220M USD (2024) |
23andMe is a consumer genetics and research company that helps people access, understand, and benefit from the human genome. 23andMe was founded in 2006 and is based in South San Francisco, California.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Healthcare Services) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (California) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2021) | 1 of 1 |
Size (of disclosed) | 1 of 1 |